Neuland Laboratories Limited (NSE: NEULANDLAB), ISIN INE794A01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NEULANDLAB last traded at ₹19716.30 (+4.54%), with a 52-week range of ₹11500.00 to ₹20072.00 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 32.62%, FIIs 21.08%, DIIs 16.51%, mutual funds 12.66%.
EquiSense Score (ECS): 91/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.